Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner

It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The open conference proceedings journal 2010-01, Vol.1, p.54-60
Hauptverfasser: Orru, Christina D, Cannas, MDolores, Vascellari, Sarah, Abete, Claudia, Mandas, Antonella, Angius, Fabrizio, Cocco, Pierluigi, La Colla, Paolo, Dessi', Sandra, Pani, Alessandra
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 60
container_issue
container_start_page 54
container_title The open conference proceedings journal
container_volume 1
creator Orru, Christina D
Cannas, MDolores
Vascellari, Sarah
Abete, Claudia
Mandas, Antonella
Angius, Fabrizio
Cocco, Pierluigi
La Colla, Paolo
Dessi', Sandra
Pani, Alessandra
description It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.
doi_str_mv 10.2174/2210289201001010054
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_911150651</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>911150651</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_9111506513</originalsourceid><addsrcrecordid>eNqNTbsKAjEQDKKgqF9gk85KTXJ36pUiPhrhQLGVcOxpJJfVbCz8e3NgYeky7M4MwyxjIymmSi7SmVJSqGWuhBQRcWVpi_Uad9LY7R_eZUOiu4iT5CpP0h47Fzfta12ixasp-fqGFiiAR8v3WANS0GSIr6oKykC88AYd34EDr0NDjeOaH99RXw2F2HDQLooB61TaEgy_t8_G281pvZ88PD5f8cOlNlSCtdoBvuiSSykzMc9k8n_yA0c1TGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>911150651</pqid></control><display><type>article</type><title>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Orru, Christina D ; Cannas, MDolores ; Vascellari, Sarah ; Abete, Claudia ; Mandas, Antonella ; Angius, Fabrizio ; Cocco, Pierluigi ; La Colla, Paolo ; Dessi', Sandra ; Pani, Alessandra</creator><creatorcontrib>Orru, Christina D ; Cannas, MDolores ; Vascellari, Sarah ; Abete, Claudia ; Mandas, Antonella ; Angius, Fabrizio ; Cocco, Pierluigi ; La Colla, Paolo ; Dessi', Sandra ; Pani, Alessandra</creatorcontrib><description>It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.</description><identifier>ISSN: 2210-2892</identifier><identifier>EISSN: 2210-2892</identifier><identifier>DOI: 10.2174/2210289201001010054</identifier><language>eng</language><ispartof>The open conference proceedings journal, 2010-01, Vol.1, p.54-60</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><creatorcontrib>Orru, Christina D</creatorcontrib><creatorcontrib>Cannas, MDolores</creatorcontrib><creatorcontrib>Vascellari, Sarah</creatorcontrib><creatorcontrib>Abete, Claudia</creatorcontrib><creatorcontrib>Mandas, Antonella</creatorcontrib><creatorcontrib>Angius, Fabrizio</creatorcontrib><creatorcontrib>Cocco, Pierluigi</creatorcontrib><creatorcontrib>La Colla, Paolo</creatorcontrib><creatorcontrib>Dessi', Sandra</creatorcontrib><creatorcontrib>Pani, Alessandra</creatorcontrib><title>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</title><title>The open conference proceedings journal</title><description>It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.</description><issn>2210-2892</issn><issn>2210-2892</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNTbsKAjEQDKKgqF9gk85KTXJ36pUiPhrhQLGVcOxpJJfVbCz8e3NgYeky7M4MwyxjIymmSi7SmVJSqGWuhBQRcWVpi_Uad9LY7R_eZUOiu4iT5CpP0h47Fzfta12ixasp-fqGFiiAR8v3WANS0GSIr6oKykC88AYd34EDr0NDjeOaH99RXw2F2HDQLooB61TaEgy_t8_G281pvZ88PD5f8cOlNlSCtdoBvuiSSykzMc9k8n_yA0c1TGQ</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Orru, Christina D</creator><creator>Cannas, MDolores</creator><creator>Vascellari, Sarah</creator><creator>Abete, Claudia</creator><creator>Mandas, Antonella</creator><creator>Angius, Fabrizio</creator><creator>Cocco, Pierluigi</creator><creator>La Colla, Paolo</creator><creator>Dessi', Sandra</creator><creator>Pani, Alessandra</creator><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20100101</creationdate><title>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</title><author>Orru, Christina D ; Cannas, MDolores ; Vascellari, Sarah ; Abete, Claudia ; Mandas, Antonella ; Angius, Fabrizio ; Cocco, Pierluigi ; La Colla, Paolo ; Dessi', Sandra ; Pani, Alessandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_9111506513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Orru, Christina D</creatorcontrib><creatorcontrib>Cannas, MDolores</creatorcontrib><creatorcontrib>Vascellari, Sarah</creatorcontrib><creatorcontrib>Abete, Claudia</creatorcontrib><creatorcontrib>Mandas, Antonella</creatorcontrib><creatorcontrib>Angius, Fabrizio</creatorcontrib><creatorcontrib>Cocco, Pierluigi</creatorcontrib><creatorcontrib>La Colla, Paolo</creatorcontrib><creatorcontrib>Dessi', Sandra</creatorcontrib><creatorcontrib>Pani, Alessandra</creatorcontrib><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The open conference proceedings journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Orru, Christina D</au><au>Cannas, MDolores</au><au>Vascellari, Sarah</au><au>Abete, Claudia</au><au>Mandas, Antonella</au><au>Angius, Fabrizio</au><au>Cocco, Pierluigi</au><au>La Colla, Paolo</au><au>Dessi', Sandra</au><au>Pani, Alessandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner</atitle><jtitle>The open conference proceedings journal</jtitle><date>2010-01-01</date><risdate>2010</risdate><volume>1</volume><spage>54</spage><epage>60</epage><pages>54-60</pages><issn>2210-2892</issn><eissn>2210-2892</eissn><abstract>It is generally recognised that prion replication in the brain is associated with cholesterol changes. We now show that prion diseases are likely associated with systemic metabolic alterations that involve changes both in the content and distribution of the different pools of cellular cholesterol, free cholesterol and cholesterol esters, as well as of other cellular lipids, including phospholipids and triglycerides. The synergic anti-prion effect showed by drug combinations affecting cholesterol metabolism at different levels suggest that pharmacologic interventions restoring lipid homeostasis may represent a more successful therapeutic approach than drug treatments lowering cholesterol content per se (i.e. statins). Notably, our data also point to neutral lipid accumulation in peripheral cells as an easy-to-detect hallmark associated with disease and/or indicative of increased susceptibility to develop disease following infection.</abstract><doi>10.2174/2210289201001010054</doi></addata></record>
fulltext fulltext
identifier ISSN: 2210-2892
ispartof The open conference proceedings journal, 2010-01, Vol.1, p.54-60
issn 2210-2892
2210-2892
language eng
recordid cdi_proquest_miscellaneous_911150651
source Free E-Journal (出版社公開部分のみ)
title Pharmacologic Cholesterol Homeostasis Affects Prion Generation in a Synergistic Manner
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacologic%20Cholesterol%20Homeostasis%20Affects%20Prion%20Generation%20in%20a%20Synergistic%20Manner&rft.jtitle=The%20open%20conference%20proceedings%20journal&rft.au=Orru,%20Christina%20D&rft.date=2010-01-01&rft.volume=1&rft.spage=54&rft.epage=60&rft.pages=54-60&rft.issn=2210-2892&rft.eissn=2210-2892&rft_id=info:doi/10.2174/2210289201001010054&rft_dat=%3Cproquest%3E911150651%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=911150651&rft_id=info:pmid/&rfr_iscdi=true